Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chicago, Illinois 60611


Purpose:

The purpose of the study is to determine if the drug motexafin gadolinium will be an effective treatment for patients who have relapsed or refractory multiple myeloma.


Criteria:

Inclusion Criteria: - Relapsed or Refractory Multiple Myeloma - ≥ 18 years old - Able to provide consent for participation - ECOG status 0-2 Lab values: - ANC ≥ 1,000/µL - WBC count ≥ 2.0/µL - Hemoglobin ≥ 8.0 g/dL - Platelet count ≥ 50,000/µL - AST and ALT ≤ 2 x ULN - Total Bilirubin ≤ 2 x ULN - Creatinine ≤ 2.0 mg/dL and - Not pregnant or lactating


NCT ID:

NCT00096837


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Chicago, Illinois 60611
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 14, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.